Cargando…
Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats
BACKGROUND: Diabetic patients suffer from undesired intimal hyperplasia after angioplasty. Nicorandil has a trend to reduce the rate of target lesion revascularization. However, whether nicorandil inhibits intimal hyperplasia and the possible mechanisms underlying it remain to be determined. We aime...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826484/ https://www.ncbi.nlm.nih.gov/pubmed/27059601 http://dx.doi.org/10.1186/s12933-016-0377-6 |
_version_ | 1782426338319138816 |
---|---|
author | Zhang, Ying Qian Tian, Feng Zhou, Ying Chen, Yun Dai Li, Bo Ma, Qiang Zhang, Ying |
author_facet | Zhang, Ying Qian Tian, Feng Zhou, Ying Chen, Yun Dai Li, Bo Ma, Qiang Zhang, Ying |
author_sort | Zhang, Ying Qian |
collection | PubMed |
description | BACKGROUND: Diabetic patients suffer from undesired intimal hyperplasia after angioplasty. Nicorandil has a trend to reduce the rate of target lesion revascularization. However, whether nicorandil inhibits intimal hyperplasia and the possible mechanisms underlying it remain to be determined. We aimed at assessing the effect of nicorandil on intimal hyperplasia in diabetic rats. METHODS: After intraperitoneal injection of streptozotocin (STZ, 50 mg/kg), balloon injury model was established in carotid arteries of diabetic rats. Rats were randomized to vehicle, nicorandil (15 mg/kg/day) or 5-hydroxydecanoate (5-HD, 10 mg/kg/day), a mitochondrial ATP-sensitive potassium channel (mitoK(ATP) channel)-selective antagonist. Perivascular delivery of εPKC siRNA was conducted to determine the role of εPKC pathway in intimal hyperplasia. In hyperglycemia environment (25 mM glucose), primary culture of vascular smooth muscle cells (VSMCs) were treated with nicorandil or 5-HD. Cell proliferation and cell migration were analyzed. RESULTS: Intimal hyperplasia significantly increased 14 days after balloon injury in diabetic rats (p < 0.01). Nicorandil inhibited intima development, reduced inflammation and prevented cell proliferation in balloon-injured arteries (p < 0.01). The protective effects of nicorandil were reversed by 5-HD (p < 0.05). εPKC was activated in balloon-injured arteries (p < 0.01). Nicorandil inhibited εPKC activation by opening mitoK(ATP) channel. Perivascular delivery of εPKC siRNA inhibited intimal hyperplasia, inflammation and cell proliferation (p < 0.01). High glucose-induced VSMCs proliferation and migration were inhibited by nicorandil. εPKC activation induced by high glucose was also inhibited by nicorandil and that is partially reversed by 5-HD. εPKC knockdown prevented VSMCs proliferation and migration (p < 0.01). CONCLUSIONS: Our study demonstrates that nicorandil inhibits intimal hyperplasia in balloon-injured arteries in diabetic rats. Nicorandil also prevents VSMCs proliferation and migration induced by high glucose. The beneficial effect of nicorandil is conducted via opening mitoK(ATP) channel and inhibiting εPKC activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0377-6) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4826484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48264842016-04-10 Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats Zhang, Ying Qian Tian, Feng Zhou, Ying Chen, Yun Dai Li, Bo Ma, Qiang Zhang, Ying Cardiovasc Diabetol Original Investigation BACKGROUND: Diabetic patients suffer from undesired intimal hyperplasia after angioplasty. Nicorandil has a trend to reduce the rate of target lesion revascularization. However, whether nicorandil inhibits intimal hyperplasia and the possible mechanisms underlying it remain to be determined. We aimed at assessing the effect of nicorandil on intimal hyperplasia in diabetic rats. METHODS: After intraperitoneal injection of streptozotocin (STZ, 50 mg/kg), balloon injury model was established in carotid arteries of diabetic rats. Rats were randomized to vehicle, nicorandil (15 mg/kg/day) or 5-hydroxydecanoate (5-HD, 10 mg/kg/day), a mitochondrial ATP-sensitive potassium channel (mitoK(ATP) channel)-selective antagonist. Perivascular delivery of εPKC siRNA was conducted to determine the role of εPKC pathway in intimal hyperplasia. In hyperglycemia environment (25 mM glucose), primary culture of vascular smooth muscle cells (VSMCs) were treated with nicorandil or 5-HD. Cell proliferation and cell migration were analyzed. RESULTS: Intimal hyperplasia significantly increased 14 days after balloon injury in diabetic rats (p < 0.01). Nicorandil inhibited intima development, reduced inflammation and prevented cell proliferation in balloon-injured arteries (p < 0.01). The protective effects of nicorandil were reversed by 5-HD (p < 0.05). εPKC was activated in balloon-injured arteries (p < 0.01). Nicorandil inhibited εPKC activation by opening mitoK(ATP) channel. Perivascular delivery of εPKC siRNA inhibited intimal hyperplasia, inflammation and cell proliferation (p < 0.01). High glucose-induced VSMCs proliferation and migration were inhibited by nicorandil. εPKC activation induced by high glucose was also inhibited by nicorandil and that is partially reversed by 5-HD. εPKC knockdown prevented VSMCs proliferation and migration (p < 0.01). CONCLUSIONS: Our study demonstrates that nicorandil inhibits intimal hyperplasia in balloon-injured arteries in diabetic rats. Nicorandil also prevents VSMCs proliferation and migration induced by high glucose. The beneficial effect of nicorandil is conducted via opening mitoK(ATP) channel and inhibiting εPKC activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12933-016-0377-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-04-08 /pmc/articles/PMC4826484/ /pubmed/27059601 http://dx.doi.org/10.1186/s12933-016-0377-6 Text en © Zhang et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Investigation Zhang, Ying Qian Tian, Feng Zhou, Ying Chen, Yun Dai Li, Bo Ma, Qiang Zhang, Ying Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats |
title | Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats |
title_full | Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats |
title_fullStr | Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats |
title_full_unstemmed | Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats |
title_short | Nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats |
title_sort | nicorandil attenuates carotid intimal hyperplasia after balloon catheter injury in diabetic rats |
topic | Original Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826484/ https://www.ncbi.nlm.nih.gov/pubmed/27059601 http://dx.doi.org/10.1186/s12933-016-0377-6 |
work_keys_str_mv | AT zhangyingqian nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats AT tianfeng nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats AT zhouying nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats AT chenyundai nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats AT libo nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats AT maqiang nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats AT zhangying nicorandilattenuatescarotidintimalhyperplasiaafterballooncatheterinjuryindiabeticrats |